Psychological science has advanced knowledge on sexual minority (e.g., gay, bisexual) men’s health, finding that:
- Sexual minority men experience higher rates of depression, anxiety, substance use disorders, and HIV acquisitionthan heterosexual men
- Sexual minority men’s disproportionate exposure to stigma-related experiences, such as childhood bullying, family rejection, and institutional discrimination, largely explains these disparities
- These stigma-related experiences give rise to cognitive, affective, and behavioral minority stress reactions, including internalized stigma, shame, social isolation, and identity concealment, which increase risk for adverse mental health outcomes and also serve as modifiable targets for treatment
- Sexual minority men also demonstrate unique strengths and resiliencies, like social and sexual creativity, community-building, and advocacy
Based on this knowledge, our team at Yale created an identity-affirming psychotherapy to reduce the cognitive, affective, and behavioral mechanisms through which stigma erodes sexual minority men’s mental health. This treatment is called ESTEEM (Effective Skills To Empower Effective Men) and is based on the treatment structure and sequence of the Unified Protocol. The Unified Protocol was developed to address the common cognitive, affective, and behavioral mechanisms underlying several mental and behavioral health problems in the general treatment-seeking population. Therefore, this particular treatment platform lends itself well to addressing the minority stress reactions shown to underlie sexual minority men’s disproportionate risk of mental and behavioral health problems. Our team consulted with several dozen LGBTQ+ community members and mental health providers to adapt the Unified Protocol to be LGBTQ-affirmative and appropriately address minority stress.
ESTEEM is designed to help sexual minority men identify reactions to early and ongoing minority stressors that interfere with well-being, such as negative beliefs about themselves and unhealthy emotion-driven behaviors. Sexual minority men then learn new skills to navigate these stressful reactions to minority stress (e.g., addressing internalized negative social messages, assertiveness, mindfulness) and meet their personalized treatment goals.
Preliminary trials of ESTEEM with sexual minority men demonstrated its ability to reduce depression, alcohol use, and condomless anal sex. To further test the efficacy of the ESTEEM treatment in comparison to existing treatments, we recruited 254 young sexual minority men with depression, anxiety, or trauma/stress disorders and recent HIV risk behavior in New York City and Miami. Participants randomly received one of three conditions:
- ESTEEM (10 sessions with a study therapist)
- LGBTQ-affirmative counseling (10 sessions-as-usual at a local community clinic)
- HIV testing and counseling only (one session with a trained counselor)
We administered surveys and interviews to all participants at baseline and then at 4-months, 8-months, and 12-months post-baseline to determine changes in the following mental and behavioral health outcomes:
- HIV transmission risk behavior
- Depression symptoms
- Anxiety symptoms
- Psychological distress
- Substance use
Outcomes were primarily analyzed as change from baseline assessment to 8-months post-baseline and are presented in the table below.
Overall, ESTEEM was associated with improvements in all mental and behavioral health outcomes and stronger reductions in all outcomes compared to the other two conditions. Notably, ESTEEM was developed as a transdiagnostic treatment to address idiosyncratic symptom presentations; results supported its efficacy in doing so, demonstrating that ESTEEM yielded significantly stronger reductions in comorbidities compared to LGBTQ-affirmative counseling.
Because ESTEEM is a transdiagnostic treatment approach, we assessed numerous outcomes and decided – ahead of time in preregistered disclosures – to adjust our statistical significance value for the number of analyses we performed. This reduced the trial’s ability to find statistically significant effects. Nonetheless, the overall pattern of results support the promise of ESTEEM. For instance, effect sizes for condition comparisons favored ESTEEM for every outcome and were in the small-to-moderate range – similar to or larger than most existing interventions for gay and bisexual men’s mental and behavioral health reported in a recent meta-analysis. Future trials that examine multiple outcomes might consider analytic approaches that assess changes in idiographic symptom presentations – e.g., reductions in only those problems with which participants present – rather than examining all outcomes for all participants and thereby reducing statistical power to detect effects.
Pachankis, J. E., Harkness, A., Maciejewski, K. R., Behari, K., Clark, K. A., McConocha, E., Winston, R., Adeyinka, O., Reynolds, J., Bränström, R., Esserman, D. A., Hatzenbuehler, M. L., Safren, S. A. (2022). LGBQ-affirmative cognitive-behavioral therapy for young gay and bisexual men’s mental and sexual health: A three-arm randomized controlled trial. Journal of Consulting and Clinical Psychology, 90(6), 459-477. https://doi.org/10.1037/ccp0000724
- How can clinicians create an LGBTQ-affirming environment for their clients?
- Are there particular types of clients who might benefit more or less from a treatment like ESTEEM?
- What barriers and supports exist to implement a treatment like ESTEEM in practice?
- How can the ESTEEM treatment be adapted to target the stressors of different LGBTQ+ subgroups (e.g., transgender and gender diverse people, sexual minority men in other countries)?
About the Authors
Ben Eisenstadt (he/him/his) is a Postgraduate Associate for the LGBTQ Mental Health Initiative at Yale School of Public Health. His research interests include optimizing mental health treatment benefits for LGBTQ+ subpopulations as well as understanding how communities can support transgender and gender diverse mental health. He plans to apply to Ph.D. programs in clinical psychology in the fall of 2022. Ben can be contacted at email@example.com.
Dr. A.S. John Pachankis (he/him/his) is the Susan Dwight Bliss Professor of Public Health and Psychiatry at Yale University and the director of Yale’s LGBTQ Mental Health Initiative. His research examines the mental health of LGBTQ+ populations and the efficacy of LGBTQ-affirmative mental health interventions. He has published 150+ scientific papers on LGBTQ+ mental health and stigma and co-edited the Handbook of Evidence-based Mental Health Practice with Sexual and Gender Minorities (Oxford University Press).